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Abstract
Highly pathogenic avian influenza virus A/H5N1 was first officially reported in Africa in early 2006. Since the first outbreak in
Nigeria, this virus spread rapidly to other African countries. From its emergence to early 2008, 11 African countries
experienced A/H5N1 outbreaks in poultry and human cases were also reported in three of these countries. At present, little
is known of the epidemiology and molecular evolution of A/H5N1 viruses in Africa. We have generated 494 full gene
sequences from 67 African isolates and applied molecular analysis tools to a total of 1,152 A/H5N1 sequences obtained from
viruses isolated in Africa, Europe and the Middle East between 2006 and early 2008. Detailed phylogenetic analyses of the 8
gene viral segments confirmed that 3 distinct sublineages were introduced, which have persisted and spread across the
continent over this 2-year period. Additionally, our molecular epidemiological studies highlighted the association between
genetic clustering and area of origin in a majority of cases. Molecular signatures unique to strains isolated in selected areas
also gave us a clearer picture of the spread of A/H5N1 viruses across the continent. Mutations described as typical of human
influenza viruses in the genes coding for internal proteins or associated with host adaptation and increased resistance to
antiviral drugs have also been detected in the genes coding for transmembrane proteins. These findings raise concern for
the possible human health risk presented by viruses with these genetic properties and highlight the need for increased
efforts to monitor the evolution of A/H5N1 viruses across the African continent. They further stress how imperative it is to
implement sustainable control strategies to improve animal and public health at a global level.
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Introduction
Since the earliest known progenitor virus detected in China, A/
goose/Guandong/96, numerous genetic lineages of highly path-
ogenic avian influenza (HPAI) viruses of H5N1 subtype (indicated
as A/H5N1 from now on) have emerged and spread. In 2005 a
large scale outbreak of A/H5N1 led to the death of thousands of
migratory waterfowl in Qinghai Lake in North-West China.
Subsequently, the A/H5N1 virus spread westward, from Qinghai
Lake through Central Asia, Europe, the Middle East and Africa
[1]. The spread of A/H5N1 viruses across Africa raises serious
concerns regarding the sustainability of the poultry sector and
public health issues. The latter include both food security aspects
for low-income countries and the potential threat to human health
due to the extensive circulation of avian influenza viruses capable
of causing significant mortality in humans.
After its first emergence in poultry farms in early 2006 in
Nigeria [2], A/H5N1 virus was detected in many other African
countries. The first outbreak was recorded in Kaduna State,
Nigeria, in mid-January 2006 and in less than a month, the virus
was identified in Egypt, Niger and Cameroon. In April 2006 the
virus was also detected in Sudan, Burkina Faso, Djibouti and
Ivory Coast. A year later the virus was still widely circulating in
Africa as demonstrated by the identification of A/H5N1
outbreaks in other African countries, such as Ghana and Togo,
between May and June 2007, and Benin in December 2007. The
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were also reported in humans. In the second half of March 2006,
Egypt confirmed its first human case and since then, the WHO
has reported 56 laboratory-confirmed human cases on the
African continent of which 24 were fatal. Egypt is the African
country with the highest number of human infections with 54
confirmed cases reported to date [3]. The remaining 2 human
cases of HPAI infection in Africa were reported in Nigeria and in
Djibouti.
At present, the availability of information on the molecular
evolution of A/H5N1 in Africa is very limited. Analyses of A/
H5N1 strains isolated in 2006 have shown that different
sublineages were circulating in the continent, these were identified
as EMA 1 and EMA2 [4] or A, B, C. [5]. As far as we are aware,
information available on A/H5N1 viruses that were circulating in
Africa in 2007 is limited to the results published recently on
Nigerian strains isolated between January and February 2007 [6].
This study showed that the co-circulation of the 3 distinct
sublineages allowed for the emergence of at least two reassortant
viruses in Nigeria, one of which appears to be the predominant
virus circulating in that country.
At present there is also very limited epidemiological
information concerning the outbreaks in many of the affected
countries and our understanding of the spread of the disease is
incomplete. However, it appears to be epidemiologically
complex and linked to movements of both poultry commodities
a n dw i l db i r d s .
In the present study, we have applied molecular analysis tools to
sequence data and combined the results with epidemiological data
related to A/H5N1 viruses isolated between 2006 and early 2008
in all the affected African countries, namely Nigeria, Niger, Sudan,
Egypt, Burkina Faso, Djibouti, Ivory Coast, Ghana, Togo,
Cameroon and Benin.
Results
A total of 494 sequences was obtained in the present study,
representing the complete coding sequences for the hemagglutinin
(HA) and neuraminidase (NA) gene segments of 67 strains and full
sequence of the ORFs of 60 A/H5N1 HPAI viruses isolated in
Africa from February 2006 to early 2008. At the time of this
investigation, they represented 60% of the sequences deposited in
public databases (GenBank and GISAID) originating from African
viruses.
The majority of the African sequences deposited in the public
databases prior to the present study were representative of the
gene segments encoding the surface proteins HA and, to a lesser
extent, NA. Sequences of the six internal segments generated for
this study account for 74% of the total number of African
internal gene segment sequences publicly available at the time of
writing.
Phylogenetic analysis
Phylogenetic trees generated by Bayesian methods of the HA
and NA gene segments of representative A/H5N1 viruses are
presented in Figure 1. The phylogenetic tree of the HA gene
generated by Bayesian methods, which includes the entire
sequence dataset, as well as the trees of the 8 gene segments
obtained with the neighbour-joining (N-J) method, are presented
in the supplementary material (Figures S1, S2, S3, S4, S5, S6, S7,
S8, S9).
Based on our phylogenetic analysis, all the African isolates
analyzed in the present study are related to the A/H5N1 viruses
that have been circulating in birds throughout Europe, Russia and
the Middle East since late 2005. According to the unified
nomenclature system for A/H5N1, they all belong to clade 2.2
[7] also described as EMA clade [4].
Figure 1. Bayesian trees for the HA (left) and NA (right) gene of A/H5N1 representative strains from Africa, Europe and Middle East
(clade 2.2). Different colours are used to differentiate the viruses from distinct sublineages. Posterior probabilities are indicated above branches.
Scale bar represents the number of substitutions per site. The map highlights the countries where influenza viruses were isolated. The colours of the
map are the same adopted in the phylogenetic trees indicating the sublineages of clade 2.2.
doi:10.1371/journal.pone.0004842.g001
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clade 2.2 A/H5N1 viruses (figure S1) highlights the distribution of
the African isolates in three distinct sublineages, here termed I, II,
and IV. One additional A/H5N1 sublineage (III) was identified by
phylogenetic analysis, but it does not include isolates from Africa.
Representative sequences are illustrated in figure 1. With reference
to the previous nomenclature [5], sublineages II, IV and I
corresponded to A, B and C respectively. The grouping and tree
topology remained unchanged whether using Bayesian methods or
the N-J algorithm (Figure S1 and S2). The groupings were
conserved using either a smaller subset of representative sequences
or the entire sequence dataset (Figures 1 and S1, respectively). In
particular, for the HA gene segment, grouping into I, III and IV
was well supported by statistical values as indicated in figures 1
and S1. With the larger dataset (Figure S1), Bayesian posterior
probabilities at the nodes were 98%; 68%; 97% and 84% for
sublineages I, II, III and IV, respectively.
The remaining genes were less divergent; however, the HA gene
grouping was maintained in the majority of the other genomic
segments (Figures S3 to S9), namely NA, PA, PB1 and PB2. For
PB1 and PB2, bootstrap values of .60 and .70 respectively were
observed at the nodes.
Nucleotide similarities calculated (Kimura-2p) for 1096 nucle-
otide positions of 256 HA gene sequences revealed nucleotide
divergence between sublineages ranging from 1.1% to 2%. The
highest divergent was IV, with values $1.5% of nucleotide
divergence from other sublineages, followed by III, with values
$1.2%.
Higher similarity was found between sequences of viruses
originating from the same country or from neighbouring countries
than with other geographical areas and a noticeable association
between genetic clustering and area of origin was observed in the
phylogenetic trees. This finding is particularly significant for some
countries as reported below.
Egypt. The sequences of all the Egyptian strains, isolated
between 2006 and 2008 and analysed in the present study, formed
a single monophyletic cluster together with sequences of the A/
H5N1 viruses from Gaza and Israel. This was observed for all 8
gene segments. The Egyptian strains all clustered in the sublineage
IV (figure 1). The mean nucleotide similarity for the HA gene
sequences within this sublineage was 99% (Kimura-2p).
Western and Central Africa. During 2006–2007, all 3
sublineages (I, II and IV) were circulating in this region of Africa.
A close relationship was found for strains originating from Burkina
Faso, Ivory Coast, Ghana and Cameroon and their sequences
formed a single cluster in sublineage I for the 8 gene segments
(note: only the NA sequence is available for the strain isolated in
Cameroon). Interestingly, the sequences of the viruses from
Ghana, isolated in April 2007, clustered with the respective gene
segments of the strains from Burkina Faso, Ivory Coast and
Cameroon although these viruses were identified one year before
the detection of the Ghanaian isolates. In contrast, the viruses
isolated in June 2007 in Togo are genetically distinct from the
isolates collected in the West African countries mentioned above,
despite being isolated within a few months of each other. In the
phylogenetic trees of each of the 8 gene segments, the isolates from
Togo cluster with the Nigerian strains isolated in 2006 and
belonging to the sublineage II. The sequence similarity between
the Togolese and the Nigerian isolates for all eight gene segments
ranged from 98.8% to 99.6%.
All sequences from Niger, obtained from isolates detected
between February and May 2006, clustered with sequences from
Nigeria isolated in 2006, and belonged to the II sublineage
(sequence similarity ranging from 99.3% to 100%). Thus, they
were genetically distinct from the viruses circulating in other
Western and Central African countries, such as Burkina Faso,
Ivory Coast, Ghana and Cameroon.
The sequences of the A/H5N1 Nigerian strains grouped in
three separated sublineages I, II and IV, in agreement with an
earlier publication [5].
The presence of viruses of different A/H5N1 sublineages in the
same geographic region creates opportunities of reassortment.
Salzberg et al [4] identified the first reassortant strain in 2006, the
A/ck/Nigeria/1047-62/2006 virus. Subsequently, phylogenetic
analysis performed on 12 Nigerian strains isolated at the beginning
of 2007 and collected in 8 Nigerian states over a 39-day period,
showed that an additional reassortant virus, with a genetic pattern
distinct from that of A/ck/Nigeria/1047-62/2006 was becoming
predominant and widespread in Nigeria [6]. The HA and NA
genes of strain, A/Nigeria/6e/2007, isolated from a woman in the
Nigerian state of Lagos, are identical to the HA and NA genes of
the predominant reassortant virus detected in poultry in 2007.
In December 2007, A/H5N1 virus was reported in Benin. Full
genome analysis showed that a close relationship exists between
the Beninese isolates and the Nigerian strains isolated in 2007. In
fact, similar reassortant A/H5N1 viruses were identified in both
Western African countries.
Eastern Africa. The six Sudanese strains analyzed in the
present study were identified in samples collected over a 15-day
period in April 2006 from distinct geographical areas of the central
part of the country. For each of the 8 gene segments, sequences
from Sudan formed a monophyletic cluster within sublineage I.
Interestingly, the Sudanese sequences were closely related to
sequences from West Africa, specifically from Nigeria, Burkina
Faso and Ivory Coast (e.g. a range of 99.5–99.7% sequence
similarity for the HA gene), rather than to sequences from
Djibouti, Egypt and the Middle East.
The sequencing of the human isolate A/Djibouti/5691/
NAMRU3/06 (note: only the HA sequence is available) revealed
100% sequence similarity with another human isolate A/Egypt/
2782/NAMRU3/06 and, consequently, falls into sublineage IV.
(figure 1).
Molecular characterization
For all viruses first characterized in this study, the amino acid
sequences of the entire genome were determined and analysed to
identify specific mutations previously identified as being associated
with modified antiviral sensitivity and enhanced replication and
virulence in mammalian species. In order to present a more
complete picture of the genetic properties of the viruses circulating
in Africa, the amino acid sequences of the African viruses available
in the public database were also included in the present analysis.
For ease of reference and to highlight the significance of the
molecular changes observed, the molecular characterization
results that appear most relevant are discussed in this section.
Persistent host markers in African A/H5N1 viruses.
Previous studies identified host specific markers that discriminate
between human influenza viruses and avian influenza viruses
[8,9]. Using multiple sequence alignments, several markers of
human influenza viruses have been identified in the sequence of
African A/H5N1 viruses as shown in table 1. Finkelstein et al.
(2007) [8] described 13 persistent host markers, mainly distributed
among PB2, PA, NP and M1 genes, which are 100% conserved in
the influenza viruses that caused the 1918, 1957 and 1968
pandemics. Two of the 13 host markers in the pandemic isolates
were found in the PB2 gene of African A/H5N1 isolates. In
particular, all the A/H5N1 viruses isolated in this continent
possess the marker E627K in the PB2 gene, which is well-known to
Avian Influenza H5N1 in Africa
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[10,11]. The second host marker (A199S) was observed in the PB2
gene of 2 Egyptian avian viruses. This mutation was also
conserved in seasonal human influenza viruses analysed in a
previous study [8].
Molecular changes associated with antiviral drugs
resistance. Mutations associated with modified sensitivity
toward antiviral drugs have been recognized in 6 African A/
H5N1 viruses.
Sequences of the M gene of 4 viruses isolated in Egypt in 2007–
2008 (A/ck/Egypt/1709-5/2008, A/ck/Egypt/1709-6/2008, A/
ck/Egypt/1709-8VIR08/2007 and A/tk/Egypt/1709-9VIR08/
2007) showed the substitution S31N in the M2 protein (table 2).
This mutation is associated with resistance to the M2 ion channel-
blocking adamantane derivates and it has been reported in the M2
protein of A/H5N1 viruses isolated from humans and poultry in
Hong Kong, Vietnam, Thailand, Indonesia and Cambodia
[12,13].
Importantly, none of the mutations known to be related to
resistance to neuraminidase inhibitors [14] were observed in any
of the African viruses isolated from birds. However, viruses A/
Egypt/14725-NAMRU3/2006 and A/Egypt/14724-NAMRU3/
2006, isolated from two patients who died of pneumonia,
possessed the mutation N294S (N2 numbering, table 2) [15].
The N294S substitution in the N1 subtype confers resistance to
oseltamivir and a slightly reduced susceptibility to zanamivir. One
A/H5N1 isolate containing this mutation had been isolated from a
patient with a A/H5N1 virus infection in Vietnam after
oseltamivir treatment [16]
Further molecular changes described in the literature as
responsible for loss of sensitivity toward adamantane treatment
have been recognised in the African isolates and are recorded in
table 2.
Mutations in the receptor binding domains and
geographical molecular signature in the HA. The receptor
binding site of the HA gene of all the analysed viruses possesses
amino acid residues Gln 226 and Gly 228 (H3 numbering) that
preferentially recognize SAa2,3Gal linkages of avian receptors
[17]. In A/H5N1 strains isolated in Egypt, several substitutions
were found in the receptor binding domain, or close proximity to it
(table 3). It is important to note that an A/H5N1 strain isolated in
Egypt from a human case possesses the mutation S227N (H3
numbering). This mutation is located in the 220-loop of the
receptor binding site (RBS) [18] and a previous study
demonstrated that mutant isolates with an asparagine at position
227 may be able to influence SAa2,6Gal recognition [19]. This
mutation was observed previously in A/H5N1 viruses isolated
from human cases in 2003 (A/Hong Kong/212/2003 and A/
Hong Kong/213/2003) [20,21].
Unique amino acid signatures in the haemagglutinin molecule
were identified in African viruses circulating in a given country or
geographical area, specifically R341G for Sudan, P251S for Egypt,
T175I for Togo, and S16G for Ivory Coast, Ghana and Burkina
Faso (H5 numbering), resulting in a clear association between
Table 1. Typical amino acid signature of human influenza viruses observed in the African strains.
Protein aa position Predicted aa Reference Strains Mutation
Avian Human
661 A T [34] A/ck/Ghana/2534/07 A661T
PB2 [34]
199 A S [9] A/ck/Egypt/5169-5/07; A/dk/Egypt/5169-6/07 A199S
627 E K [8] All strains analysed in this study E627K
73 K R [9] All strains analysed in this study belonging to IV sublineage K73E
A/dk/Egypt/452-1/06; A/ck/Egypt/452-2/07
PB1-F2 82 L S [9] A/dk/Egypt/5169-1/07; A/dk/Egypt/5169-4/07 L82S
A/ck/Egypt/5169-5/07; A/Egypt/902786/06
79 R Q [9] A/ck/Egypt/5169-3/07 R79Q
A/ck/Nigeria/1071-3/07; A/ck/Nigeria/1071-7/07
PA 100 V A [7,34] A/ck/Nigeria/AB13/06; A/ck/Nigeria/AB14/06 V100A
400 Q/T/S L [34] A/dk/Egypt/1709-3VIR08/07; A/ck/Egypt/2628-2/07 S400L
356 K R [9] A/ck/Burkina Faso/1347-16/06 K356R
[34]
NP 33 V I [9] 78/81 viruses V33I
A/ck/Egypt/5169-2/07; A/ck/Egypt/5169-3/07
109 I V [9] A/ck/Nigeria/1047-8/06 I109V
A/ck/Sudan/1784-8/06; A/ck/Sudan/1784-7/06
M2 55 L F [34] A/ck/Sudan/1784-10/06; A/ck/Sudan/2115-9/06 L55F
A/ck/Sudan/2115-12/06; A/ck/Sudan/2115-10/06
A/hooded vulture/BurkinaFaso/2/06
[9]
NS1 227 E R o K (H1N1) [8] A/ck/Nigeria/FA4/06; A/ck/Nigeria/FA7/06 E227G
NS2 70 S G [9] A/ck/Nigeria/FA4/06; A/ck/Nigeria/FA7/06 S70G
doi:10.1371/journal.pone.0004842.t001
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analysis (two-sided Fisher’s exact test) confirmed that these four
unique molecular signatures occurred almost exclusively within
the specified countries, much more frequently than expected by
chance (P,0.001, Fisher’s exact test). This is also reflected in the
phylogenetic analysis of the same viruses. Interestingly, the
sequence derived from the human isolate from Djibouti showed
the same molecular signature as the Egyptian/Palestinian/Israeli
strains. It is also worth noting that the signature P251S was present
in 141 out of 142 Egyptian isolates from both poultry and humans.
The only exception was detected in one of the first viruses isolated
in Egypt in 2005 from wild birds (A/teal/Egypt/14051-
NAMRU3/2005, table 4).
Discussion
Considering the number of sequences (n. 1152; of which 832 are
from Africa) and epidemiological data collected and analysed
herein, this study provides unique and comprehensive information
concerning the A/H5N1 epidemic in the whole African continent
from its appearance in 2006 to early 2008.
The phylogenetic results obtained in the present study indicate
that, since the first Nigerian outbreak in early 2006, the Qinghai-
lineage viruses (clade 2.2) has been the only clade isolated in
Africa. This also sheds some light on the possible origins of the A/
H5N1 viruses in Africa and confirmed previous results obtained
with a smaller sequence dataset [4] indicating the viruses
circulating in Russia in 2005 were the potential progenitors of
the A/H5N1 virus that subsequently spread in Europe and Africa.
As long as the virus continues to circulate and evolve, new clades
may emerge in the future from the sublineages described here. As
an example, currently circulating sublineage IV viruses in Egypt
revealed genetic features that meet the criteria for a new, third
order clade definition according to WHO nomenclature [7].
Shortly after the first Nigerian notification, A/H5N1 outbreaks
were reported by other African countries, not only those bordering
Nigeria, such as Niger, but also in more distant countries such as
Burkina Faso and Egypt. The genetic analyses, performed on the
A/H5N1 viruses representative of the first outbreaks in these
countries, showed that 3 distinct sublineages of the A/H5N1 virus
had been co-circulating since the beginning of the epidemic in
Africa, suggesting multiple introductions had occurred, as reported
in previous studies [4,5,22]. The results of the phylogenetic
analysis showed that, for the period covered by this study, no
further genetic sublineages were introduced into Africa. The new
outbreaks subsequently reported, in chronological order, in Sudan,
Ivory Coast, Djibouti, Ghana, Togo and Benin were caused by
viruses all placed in the three known genetic sublineages
circulating in Africa since early 2006, namely I, II and IV. In
particular, it is interesting to underline that the EMA3 sublineage
[4], here named sublineage III (Fig. 1), widely circulating in
Europe, the Middle East and in some Asian countries during 2006
and 2007 together with the other three sublineages, had
apparently not spread to Africa up to early 2008.
Some of the genetic diversity observed among viruses isolated in
Africa between 2006 and early 2008 is likely to be related to the
prolonged circulation of the A/H5N1 viruses in distinct poultry
populations in different geographical areas, rather than to
constantly recurring new virus introductions. The detailed
phylogenetic and molecular analysis of A/H5N1 influenza viruses
from different regions in Africa isolated between 2006 and 2007
shows that the continuing circulation of these viruses in poultry has
resulted in the establishment of geographically distinct groups
within the three sublineages identified in this continent. This data
is confirmed by both the distinct topology of the viruses in the
phylogenetic tree and the identification of unique molecular
signatures in the HA sequences of the viruses circulating in a given
country or region (table 4). The clustering of the African sequences
with geographical origin may suggest that a certain degree of
geographical segregation has occurred in Africa after the virus was
first introduced into a given area. This is particularly evident for
the viruses identified in Egypt, Israel and Gaza, which cluster
together in the same branch of the phylogenetic tree and are
distinguishable from the other African viruses. Similarly, the
sequences of the isolates collected in neighbouring countries of
West Africa, such as Burkina Faso, Ivory Coast and Ghana are
Table 2. Substitutions that can alter the sensitivity of A/H5N1 African viruses to antiviral drugs.
Susceptibility of avian influenza viruses to neuraminidase inhibitors
Position Residue in NA Substitution associated with resistance Reference Strains Mutation
294* N S [15] A/Egypt/14725-NAMRU3/06 N294S
A/Egypt/14724-NAMRU3/06
Susceptibility of avian influenza viruses to adamantanes
Position Residue in M2 Substitution associated with resistance Reference Strains Mutation
A or T [33] A/ck/Burkina Faso/13.1/06 V27I 27 V
V or A or I [12]
A/avian/Togo/3618-10/07 30 A T or V [33]
A/ck/Togo/4106-1/07
A30S
S [12]
A/ck/Togo/4106-4/07
A/ck/Egypt/1709-5/08 31 S N [12]
A/ck/Egypt/1709-6/08
S31N
[13]
A/ck/Egypt/1709-8VIR08/07
A/tk/Egypt/1709-9VIR08/07
*N2 numbering.
doi:10.1371/journal.pone.0004842.t002
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A/H5N1 viruses, which also formed a separate cluster, showed
distinct genetic features compared to the sequences of the viruses
isolated in the bordering or neighbouring countries, such as Egypt
and Djibuti. Surprisingly, viruses circulating in Sudan were most
closely related to isolates from Nigeria, Burkina Faso and Ivory
Coast highlighting the complexity of the epidemiological connec-
tions within African countries and suggesting that the virus found
suitable conditions to move across national borders from East to
West Africa - and vice versa- by so far unidentified animate or
inanimate vehicles.
Furthermore, based on the phylogenetic analyses and the
genetic signatures described in the present study, the origin of the
virus in Djibouti can be traced back to Egypt, Israel or Palestine.
Coupling this genetic data with the epidemiological information
available regarding the Djibouti case (i.e. one single non-fatal case
in human, absence of reported cases of the disease in poultry, place
of isolation), it seems likely that the origins of this case were in one
of those three countries. From the present study, the origins and
the possible roles of the location-specific amino acid signatures
detected in the HA sequences (table 4) remain a matter of
speculation. However, the absence of the signature P239S in one
of the first viruses collected in Egypt from a wild bird, might
suggest that the appearance of this distinct substitution occurred
after the introduction and spread of the viruses into separate
poultry populations.
Even if new genetic sublineages have not been detected in
Africa in the period covered in this study, A/H5N1 viruses with a
new gene constellation were identified in Nigeria in 2007 [6]. The
co-circulation of viruses belonging to distinct sublineages was
responsible for the emergence of a reassortant strain in Nigeria,
namely EMA1/EMA2-2:6R07 virus, which corresponded to the
Table 3. Substitutions in the HA glycoprotein of African A/H5N1 viruses.
Virus strains Position*
1 Mutations at RBS or adjacent to it
A/Egypt/0636-NAMRU3/2007; A/Egypt/1394-NAMRU3/07; A/Egypt/2621-NAMRU3/2007 133 Deletion
A/Egypt/2629-NAMRU3/2007; A/Egypt/2631-NAMRU3/2007; A/ck/Egypt/R2/07; A/ck/Egypt/R3/07
A/ck/Egypt/R4/07; A/ck/Egypt/R5/07; A/ck/Egypt/R6/07; A/ck/Egypt/9400NAMRU3-CLEVB211/07 155 I155T
A/chicken/Nigeria/1071-10/2007; A/chicken/Nigeria/1071-22/2007;
A/chicken/Egypt/3044NAMRU3-CLEVB59/2007; A/chicken/Egypt/3045NAMRU3-CLEVB60/2007
133 S133L
A/chicken/Egypt/3046NAMRU3-CLEVB62/2007; A/crow/Egypt/9382NAMRU3-CLEVB111/2007
A/chicken/Egypt/9383NAMRU3-CLEVB112/2007; A/chicken/Egypt/9384NAMRU3-CLEVB118/2007
A/dk/Egypt/5169-1/07 186 N186S
A/Egypt/2947-NAMRU3/06 227 S227N
32 Egyptian strains 230 M230I
11 Egyptian strains 230 M230V
Virus strains Position*
2 Additional glycosylation site
A/ck/Egypt/1079-NAMRU3/07 70 NCS
A/ck/Egypt/1709-5/2008; A/ck/Egypt/1709-6/2008; A/chicken/Egypt/1709-8VIR08/2007
A/ck/Egypt/07201-NLPQ/07; A/ck/Egypt/07202-NLPQ/07; A/ck/Egypt/07203-NLPQ/07;
A/ck/Egypt/07632S-NLPQ/07; A/ck/Egypt/07701S-NLPQ/07; A/ck/Egypt/086Q-NLPQ/08;
A/ck/Egypt/088S-NLPQ/08
88 NVS
A/ck/Egypt/9402NAMRU3-CLEVB213/07; A/ck/Egypt/9403NAMRU3-CLEVB214/07
A/Egypt/6251-NAMRU3/07; A/dk/Egypt/9399NAMRU3-CLEVB202/07 252 NDT or NDS
A/chicken/Egypt/9385NAMRU3-CLEVB125/2007; A/chicken/Egypt/9386NAMRU3-CLEVB136/2007
A/chicken/Egypt/9387NAMRU3-CLEVB148/2007; A/chicken/Egypt/9390NAMRU3-CLEVB157/2007
135 NSS
A/chicken/Egypt/9391NAMRU3-CLEVB158/2007; A/chicken/Egypt/9392NAMRU3-CLEVB167/2007
Virus strains Cleavage site
Isolates from Sudan PQGEGRRKKR*GLF
Isolates from Egypt PQGKRRRKKR*GLF
PQRERRRKKR*GLF
PQGEKRRKKR*GLF
PQGERRRRKR*GLF
PQGERRRKRR*GLF
PQGERRRKKR*GLF
Isolates from Nigeria PQGERRRRKR*GLF
PQGERRRKKR*GLF
Isolates from Niger, Ivory Coast, Burkina Faso, Ghana, Benin, Togo and Djibouti PQGERRRKKR*GLF
*1H3 numbering.
*2H5 numbering.
doi:10.1371/journal.pone.0004842.t003
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here. The present study has revealed that the spread of this
reassortant was not confined to Nigeria. One A/H5N1 virus with
an identical genetic pattern (I/II-2:6) was identified among
samples collected during the Benin outbreak in December 2007,
suggesting that this reassortant was introduced in this country from
bordering Nigeria or from a common unknown.
By analysing the epidemiological and phylogenetic data
presented in this study simultaneously, it was possible to determine
that the initial A/H5N1 outbreaks reported in neighbouring
countries Ghana and Togo, in April and June 2007 respectively,
were caused by A/H5N1 viruses belonging to separate sublineages
despite the geographical proximity and the narrow time period
between the two outbreak notifications. These findings support the
hypothesis that the Ghanaian and Togolese outbreaks are not
linked epidemiologically and were the result of distinct introduc-
tions from different sources. Surprisingly, the analyses performed
in the present study demonstrated that the most recent 2007
Ghanaian isolates clustered together with early strains obtained
from Burkina Faso and Ivory Coast in 2006, rather than with the
contemporaneous viruses identified in 2007. Considering that no
further outbreaks were reported in Burkina Faso and Ivory Coast
during 2007, the exact time of introduction of the A/H5N1 virus
into Ghana remains obscure. It could be suggested that an early
epidemiological connection between the three countries may exist
or that the virus circulated undetected in that area for some time.
Similarly, the origin of the 2007 Togolese strains is difficult to
determine, although the phylogenetic analysis suggested that there
may have been a close epidemiological link with viruses widely
circulating in Nigeria in 2006.
Phylogenetic analysis of all gene segments of the A/H5N1
viruses in this study did not allow us to pinpoint the origins of the
different viruses and it remains unclear how the three distinct A/
H5N1 sublineages entered the continent and spread so rapidly.
The difficulties encountered in tracing the spread and evolution of
this virus in Africa reflect the insufficient level of resources locally
available for the epidemiology, diagnosis and characterization of
this infectious organism and the limitations of the surveillance
programs currently implemented in some African regions.
However, based on the genetic data presented above, some
hypotheses can be put forward on the introduction and
mechanisms of spread of the A/H5N1 in Africa. In a similar
manner to what occurred at about the same period of time in
Europe, different viruses were introduced separately into Africa as
already distinguishable sublineages, possibly from Central Russia
[4,23].The first detection of A/H5N1 virus in Africa occurred at a
time when viruses showing common phylogeny were known to be
present in Eurasian wild migratory birds [23] and such birds may
have played a significant role in the introduction of the virus. After
the first introduction of the A/H5N1 virus into a given area in
Africa, virus populations seemed to have evolved independently,
acquiring specific mutations. This suggests limited virus exchange
among geographically separated susceptible host populations,
which reflects the poultry economy and poultry trade in Africa.
Indeed, these are mainly based on local/regional trade of rural
poultry rather than on expanded/international import/export
typical of the industrial poultry sectors elsewhere [24].
The application of more refined molecular tools and detailed
evolutionary analysis to the genetic data now available will
contribute to elucidate some aspects of this complex epidemiolog-
ical situation.
In addition to virulence markers that are present in most
Qinghai-lineage viruses (lineage 2.2), such as the PB2 E627K
mutation, some African isolates from domestic birds exhibited
mutations described as typical of human viruses in the genes
encoding for internal proteins (table 1). Several mutations
associated with host adaptation and to increased resistance to
antiviral drugs have also been detected in the genes encoding
transmembrane proteins (table 2). Although the possible epidemi-
ological and pathogenetic roles of these amino acids substitutions
have not yet been fully investigated, these findings raise concerns
for the possible human health implications of viruses with these
genetic characteristics.
The continued circulation of A/H5N1 viruses in the African
continent not only affects the local economy but also impacts on
animal and human health. It is imperative that constant efforts are
undertakento continue tomonitor the evolutionofA/H5N1viruses
across the African continent and to implement sustainable control
strategies to improve animal and public health at a global level.
Materials and Methods
Samples
Between 2006 and early 2008, the OIE/FAO Reference
Laboratory for avian influenza at IZSVe, Padua, Italy, received
and analysed 4,587 samples collected in wild and domestic birds
from 15 African countries. All the samples were screened by Real
Time RT-PCR (rtRT-PCR) targeting the influenza A specific M
gene [25]. Positive samples were typed by rtRT-PCR protocols
specific for H5, H7 and H9 subtypes [26].
Table 4. Unique amino acid changes in the HA protein identified in A/H5N1 viruses circulating in a given country or geographical
area.
Country aa substitution No. HA sequences No. HA sequences with characteristic substitution
Sudan R341G 6 6
Egypt 142 Egypt 141 Egypt *
1
Djibouti P251S*
2 1 Djibouti 1 Djibouti
Ghana 4 Ghana 4 Ghana
Ivory Coast S16G*
3 7 Ivory Coast 7 Ivory Coast
Burkina Faso 10 Burkina Faso 10 Burkina Faso
Togo T175I 3 3
*1except for A/teal/Egypt/14051-NAMRU3/2005.
*2substitution observed also in the A/H5N1 strains from Gaza and Israel.
*3substitution found also in the A/H5N1 strain A/ck/Crimea/04/2005.
doi:10.1371/journal.pone.0004842.t004
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collected in poultry and submitted from 9 of these countries. Sixty-
seven representative African A/H5N1 strains were selected for
antigenic and genomic analysis based on the country of origin,
place and date of collection. Information regarding the viruses
analyzed in the present study is recorded in table S1. All the
laboratory analyses were performed at the IZSVe OIE/FAO
Reference Laboratory. No animal experiments were conducted for
this study.
Virus isolation, nucleotide sequencing
Viruses were grown in 9- to 10-day-old embryonated specific
pathogen free (SPF) fowls’ eggs. The number of virus passages in
eggs was limited to one in order to restrict genome modifications
linked to laboratory manipulation. Subtype identification of the
viruses was determined by standard haemagglutination inhibition
and neuraminidase inhibition tests [27,28].
Viral RNA was extracted from the infective allantoic fluid of
SPF fowls’ eggs using the Nucleospin RNA II Kit (Machery-
Nagel, Duren, Germany) and was reverse transcribed with the
SuperScript III Reverse Transcriptase kit (Invitrogen, Carlsbad,
CA - USA). PCR amplification was performed by using specific
primers (primer sequences available on request). The complete
coding sequences were generated using the Big Dye Terminator
v3.1 cycle sequencing kit (Applied Biosystem, Foster City, CA -
USA). The products of the sequencing reactions were cleaned-up
using PERFORMA DTR Ultra 96-Well kit (Edge BioSystems,
Gaithersburg, MD - USA) and sequenced in a 16-capillary ABI
PRISM 31306l Genetic Analyzer (Applied Biosystem, Foster
City, CA - USA). Sequences from all eight gene segments were
aligned and compared with A/H5N1 sequences of viruses from
Africa (n=338) and with representative sequences of viruses
from Europe and the Middle East (n=320) available on
GenBank.
Phylogenetic analysis
Phylogenetic analyses were carried out for all the eight gene
segments using the neighbour-joining (N-J) method with 1000
bootstrap replicates implemented in the MEGA 4 programme
[29]. Topology of the HA and NA tree obtained was then
compared to the topology of the trees generated with Bayesian
methods using both the entire sequence dataset for the HA gene
and a subset of sequences for the HA and NA. In detail, the
selection of the most appropriate model of molecular evolution
was obtained using the Akaike information criterion implemented
in the computer program ModelTest v3.7 [30]. For HA and NA
genes, the best-fit model of nucleotide substitution was identified as
the general reversible GTR+I+C4 model, with the frequency of
each substitution type, proportion of invariant sites (I), and gamma
distribution of among-site rate variation with four rate categories
(C4) estimated from the empirical data (parameter value available
upon request). Bayesian methods implemented with the computer
program MrBayes v3.1.1 [31,32] were applied to generate the
dendrograms and to assess statistical supports for the branches
from 16,000 trees generated from the original dataset. The
sequences obtained for this study were all deposited in public
databases (GenBank and GISAID). Accession numbers are
provided in Table S2.
Supporting Information
Table S1 List of H5N1 influenza viruses sequenced and
analyzed for the present study.
Found at: doi:10.1371/journal.pone.0004842.s001 (0.10 MB
DOC)
Table S2 List of H5N1 influenza sequences deposited for the
present study
Found at: doi:10.1371/journal.pone.0004842.s002 (0.09 MB
DOC)
Figure S1 Bayesian trees for the HA gene of 270 H5N1 strains
representative of the whole data set used in this study. Posterior
probabilities are indicated at the nodes. Scale bar represents the
number of substitutions per site.
Found at: doi:10.1371/journal.pone.0004842.s003 (1.55 MB TIF)
Figure S2 Phylogenetic tree for the HA gene of 270 H5N1
strains representative of the whole data set used in this study. The
tree was obtained using the neighbour-joining method with 1000
bootstrap replicates implemented in the MEGA 4 programme.
Bootstrap values .50 are indicated at the nodes.
Found at: doi:10.1371/journal.pone.0004842.s004 (8.25 MB TIF)
Figure S3 Phylogenetic tree for the NA gene of 148 H5N1
strains representative of the whole data set used in this study. The
tree was obtained using the neighbour-joining method with 1000
bootstrap replicates implemented in the MEGA 4 programme.
Bootstrap values .50 are indicated at the nodes.
Found at: doi:10.1371/journal.pone.0004842.s005 (3.74 MB TIF)
Figure S4 Phylogenetic tree for the M gene of 126 H5N1 strains
representative of the whole data set used in this study. The tree
was obtained using the neighbour-joining method with 1000
bootstrap replicates implemented in the MEGA 4 programme.
Bootstrap values .50 are indicated at the nodes.
Found at: doi:10.1371/journal.pone.0004842.s006 (5.44 MB TIF)
Figure S5 Phylogenetic tree for the PB1 gene of 134 H5N1
strains representative of the whole data set in this study. The tree
was obtained using the neighbour-joining method with 1000
bootstrap replicates implemented in the MEGA 4 programme.
Bootstrap values .50 are indicated at the nodes.
Found at: doi:10.1371/journal.pone.0004842.s007 (4.90 MB TIF)
Figure S6 Phylogenetic tree for the PB2 gene of 120 H5N1
strains representative of the whole data set used in this study. The
tree was obtained using the neighbour-joining method with 1000
bootstrap replicates implemented in the MEGA 4 programme.
Bootstrap values .50 are indicated at the nodes.
Found at: doi:10.1371/journal.pone.0004842.s008 (3.90 MB TIF)
Figure S7 Phylogenetic tree for the PA gene of 121 H5N1
strains representative of the whole data set in this study. The tree
was obtained using the neighbour-joining method with 1000
bootstrap replicates implemented in the MEGA 4 programme.
Bootstrap values .50 are indicated at the nodes.
Found at: doi:10.1371/journal.pone.0004842.s009 (3.52 MB TIF)
Figure S8 Phylogenetic tree for the NP gene of 117 H5N1
strains representative of the whole data set used in this study. The
tree was obtained using the neighbour-joining method with 1000
bootstrap replicates implemented in the MEGA 4 programme.
Bootstrap values .50 are indicated at the nodes.
Found at: doi:10.1371/journal.pone.0004842.s010 (4.20 MB TIF)
Figure S9 Phylogenetic tree for the NS gene of 123 H5N1
strains representative of the whole data set used in this study. The
tree was obtained using the neighbour-joining method with 1000
bootstrap replicates implemented in the MEGA 4 programme.
Bootstrap values .50 are indicated at the nodes.
Found at: doi:10.1371/journal.pone.0004842.s011 (3.90 MB TIF)
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